UPDATE: Galena Biopharma (GALE) Stock Hit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Galena Biopharma (GALE) Gains Following Positive Comments from Doctor
February 20, 2014 10:38 AM ESTGalena Biopharma (Nasdaq: GALE) gained following positive comments from a medical oncologist and hematologist posted on Seeking Alpha. Link Here... More
Galena Biopharma (GALE) Responds to TheStreet.com
February 14, 2014 3:26 PM ESTGalena Biopharma (Nasdaq: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today issued a letter to its shareholders in response to recent media attention stemming from an article by TheStreet.com.
Dear Shareholders:
Due to the recent media attention on Galena Biopharma that we acknowledge is having an impact on investor confidence, we felt it necessary, as a service to our shareholders, to publicly respond to the discussions and set the record straight.
The... More
UPDATE: Galena Biopharma (GALE) Declines Following Negative Comments from Adam Feuerstein
February 12, 2014 10:02 AM EST(Updated - February 12, 2014 10:11 AM EST)
Galena Biopharma (Nasdaq: GALE) stock declined on Wednesday after negative comments from TheStreet.com's Adam Feuerstein. Link Here... More
